Original Research
Published on 23 Jul 2024
HIGD1B, as a novel prognostic biomarker, is involved in regulating the tumor microenvironment and immune cell infiltration; its overexpression leads to poor prognosis in gastric cancer patients
in Cancer Immunity and Immunotherapy
![HIGD1B, as a novel prognostic biomarker, is involved in regulating the tumor microenvironment and immune cell infiltration; its overexpression leads to poor prognosis in gastric cancer patients](https://www.frontiersin.org/files/myhome article library/1415148/1415148_Thumb_400.jpg)